BindingDB logo
myBDB logout

24 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
27541271 247 Minimizing CYP2C9 Inhibition of Exposed-Pyridine NAMPT (Nicotinamide Phosphoribosyltransferase) Inhibitors.EBI Genentech Inc.
26755394 14 Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.EBI Second Military Medical University
25556090 99 Identification of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with no evidence of CYP3A4 time-dependent inhibition and improved aqueous solubility.EBI Genentech Inc.
24021463 37 Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).EBI Forma Therapeutics, Inc.
24405419 96 Fragment-based identification of amides derived from trans-2-(pyridin-3-yl)cyclopropanecarboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).EBI Genentech
24433859 80 Fragment-based design of 3-aminopyridine-derived amides as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).EBI Genentech
24279990 14 Discovery of potent and efficacious cyanoguanidine-containing nicotinamide phosphoribosyltransferase (Nampt) inhibitors.EBI Forma Therapeutics, Inc.
24164086 17 Nicotinamide phosphoribosyltransferase inhibitors, design, preparation, and structure-activity relationship.EBI Topotarget A/S
23679915 11 Medicinal chemistry of nicotinamide phosphoribosyltransferase (NAMPT) inhibitors.EBI Universit£ degli Studi del Piemonte Orientale"A. Avogadro"
23899614 60 Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).EBI Genentech Inc
23859118 60 Structure-based discovery of novel amide-containing nicotinamide phosphoribosyltransferase (nampt) inhibitors.EBI Forma Therapeutics, Inc.
23668988 81 Discovery of potent and efficacious urea-containing nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with reduced CYP2C9 inhibition properties.EBI Genentech
23617784 74 Structure-based identification of ureas as novel nicotinamide phosphoribosyltransferase (Nampt) inhibitors.EBI Forma Therapeutics, Inc.
21080724 57 Analogues of 4-[(7-Bromo-2-methyl-4-oxo-3H-quinazolin-6-yl)methylprop-2-ynylamino]-N-(3-pyridylmethyl)benzamide (CB-30865) as potent inhibitors of nicotinamide phosphoribosyltransferase (Nampt).EBI Myrexis, Inc.
21330015 2 Design, synthesis and X-ray crystallographic study of NAmPRTase inhibitors as anti-cancer agents.EBI School of Life Science
24797455 5 Structural and biochemical analyses of the catalysis and potency impact of inhibitor phosphoribosylation by human nicotinamide phosphoribosyltransferase.BDB Genentech, Inc. 1 DNA Way, South San Francisco, California 94080 (USA).
20609415 6 Chemical proteomics identifies Nampt as the target of CB30865, an orphan cytotoxic compound.BDB Myriad Pharmaceuticals